Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

April 18, 2022

Study Completion Date

April 18, 2022

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

Dosing 1: Atomoxetine

Oral administration at bedtime

DRUG

AD313

Escalating dose of AD313; Oral administration at bedtime

Trial Locations (2)

Clayton Sleep Institute, St Louis

Santa Monica Clinical Trials, Los Angeles